Furthermore, patients with gliomas carrying the combined 1p19q deletion have a relatively favorable survival prognosis5, while MGMT methylation status is an important predictor of the glioma’s sensitivity to alkylating agent chemotherapy6,7. Here, MGMT is linked to central nervous system cancer.